← Leaderboards
Peng Yao
University Of Rochester
$6,423,925
Attributed
$6,423,925
Total exposure
5
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $993.3K · FY2016–25$1M$750K$500K$250K$0
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$6,423,925 · 5
By mechanism
R01$6,040,076 · 4
R56$383,849 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Rochester
Same institution · by research overlap
- Eric M. Phizicky$13,586,027
Others in their field
Top investigators on “Mediating”
- Bambra Strokes · Ppd Development Lp$526,656,217
- Lawrence Corey · Fred Hutchinson Cancer Center$493,822,581
- Barton F Haynes · Duke University$295,802,493
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$286,700,869
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$176,977,598
- Dan H. Barouch · Fred Hutchinson Cancer Center$122,734,499
Research focus
MediatingHeart FailureCardiac MyocytesMortalityHypertrophyPreventive InterventionMouse ModelInsightTherapeutic InterventionStressCardiacUnited StatesHeartPhenotypeMorbidity - Disease RatePathologicHeart DiseasesHeart HypertrophyKnockout MiceGenesTranslationsExhibitsNew Therapeutic TargetProtein Biosynthesis
Grant awards (15)
uORF-mediated Translational Control of Cardiac Transcription Factor Expression$507,641
R01 · FY2025 · HL · contact PI
Deciphering the role of FAM210A in cardiac physiopathology$485,673
R01 · FY2025 · HL · contact PI
uORF-mediated Translational Control of Cardiac Transcription Factor Expression$497,488
R01 · FY2024 · HL · contact PI
Deciphering the role of FAM210A in cardiac physiopathology$475,960
R01 · FY2024 · HL · contact PI
uORF-mediated Translational Control of Cardiac Transcription Factor Expression$507,641
R01 · FY2023 · HL · contact PI
Deciphering the role of FAM210A in cardiac physiopathology$485,673
R01 · FY2023 · HL · contact PI
Translational Control of Cardiac Fibrosis$385,000
R01 · FY2022 · HL · contact PI
Role of miR-574-Fam210a axis in cardiac hypertrophy and remodeling$385,000
R01 · FY2021 · HL · contact PI
Translational Control of Cardiac Fibrosis$385,000
R01 · FY2021 · HL · contact PI
Translational Control of Cardiac Fibrosis$385,000
R01 · FY2020 · HL · contact PI
Role of miR-574-Fam210a axis in cardiac hypertrophy and remodeling$385,000
R01 · FY2020 · HL · contact PI
Translational Control of Cardiac Fibrosis$385,000
R01 · FY2019 · HL · contact PI
Role of miR-574-Fam210a axis in cardiac hypertrophy and remodeling$385,000
R01 · FY2019 · HL · contact PI
Role of miR-574-Fam210a axis in cardiac hypertrophy and remodeling$385,000
R01 · FY2018 · HL · contact PI
Role of miR-574 driver and passenger strands in cardiac hypertrophy$383,849
R56 · FY2016 · HL · contact PI